Boothbay Fund Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.93M	Buy	+34,206	New	+$1.99M	0.04%	642
2025 Q4	–	Sell	-11,800	Closed	-$639K	–	1998
2025 Q3	$639K	Sell	11,800 -300	-2%	-$17.2K	0.02%	1034
2025 Q2	$665K	Buy	+12,100	New	+$713K	0.02%	814
2023 Q4	–	Hold	0	–	–	–	1680
2023 Q3	–	Hold	0	–	–	–	1763
2023 Q2	–	Sell	-25,781	Closed	-$2.43M	–	1852
2023 Q1	$2.51M	Buy	25,781 +19,019	+281%	+$1.97M	0.07%	564
2022 Q4	$700K	Buy	6,762 +1,941	+40%	+$182K	0.02%	1045
2022 Q3	$409K	Sell	4,821 -7,343	-60%	-$654K	0.01%	1340
2022 Q2	$1.01M	Buy	12,164 +6,034	+98%	+$480K	0.03%	803
2022 Q1	$473K	Sell	6,130 -3,973	-39%	-$332K	0.01%	1326
2021 Q4	$893K	Buy	+10,103	New	+$834K	0.03%	808
2021 Q2	–	Sell	-12,152	Closed	-$918K	–	1873
2021 Q1	$918K	Buy	+12,152	New	+$993K	0.05%	639
2020 Q3	–	Hold	0	–	–	–	1062
2020 Q2	–	Sell	-7,980	Closed	-$793K	–	983
2020 Q1	$674K	Buy	+7,980	New	+$688K	0.07%	394
2019 Q3	–	Hold	0	–	–	–	784
2019 Q2	–	Hold	0	–	–	–	758
2019 Q1	–	Hold	0	–	–	–	761
2017 Q2	–	Sell	-5,575	Closed	-$489K	–	682
2017 Q1	$489K	Buy	+5,575	New	+$496K	0.12%	266
2016 Q2	–	Hold	0	–	–	–	514
2016 Q1	–	Hold	0	–	–	–	341